Teva Pharmaceuticals Competitors and Similar CompaniesClear all
Teva Pharmaceuticals's competitors and similar companies include Viatris, WuXi AppTec, Merck, Novartis, Pfizer, AstraZeneca, Roche, Sanofi and Allergan.
 Viatris Viatris is a pharmaceutical company that develops and manufactures branded and generic medicines, biosimilar medicines, and over-the-counter products. |  WuXi AppTec WuXi AppTec (无锡药明康德新药开发股份有限公司, formerly known as WuXi PharmaTech) is a company that provides integrated research, development, and manufacturing solutions for drug discovery and production. |  Merck Merck (also known as MSD) is a company that develops and manufactures medicines and vaccines for human and animal health. |  Novartis Novartis is a company that researches, develops, manufactures, and markets healthcare products. |  Pfizer Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products. |  AstraZeneca AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines. |  Sanofi Sanofi is a healthcare company engaged in the research, development, manufacture, and marketing of therapeutic solutions. |  Allergan Allergan is a healthcare company focused on developing, manufacturing, and commercializing branded pharmaceutical, device, biologic, surgical, and regenerative medicine products. | |||
Founding Date | Founding Date 1901 | Founding Date 2020 | Founding Date 2000 | Founding Date 1891 | Founding Date 1996 | Founding Date 1849 | Founding Date 1999 | Founding Date 1896 | Founding Date 1994 | Founding Date 1948 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public | Type Subsidiary |
Tags | ||||||||||
Locations | Locations Petah Tikva, IL HQ Villa Adelina, AR Macquarie Park, AU Minsk, BY Antwerpen, BE Sao Paulo, BR Dupnica, BG see more | Locations Canonsburg, US HQ Carole Park, AU Millers Point, AU Campos Dos Goytacazes, BR São Paulo, BR Sofia, BG Toronto, CA see more | Locations Shanghai, CN HQ Beijing, CN Changzhou, CN Chengdu, CN Nanjing, CN Nantong, CN Shanghai, CN see more | Locations Rahway, US HQ Munro, AR Macquarie Park, AU Krems An Der Donau, AT Wien, AT Bruxelles, BE Santa Cruz De La Sierra, BO see more | Locations Basel, CH HQ Tirana, AL Buenos Aires, AR Macquarie Park, AU Kundl, AT Unterlangkampfen, AT Wien, AT see more | Locations New York, US HQ Buenos Aires, AR Villa Adelina, AR Footscray, AU Mulgrave, AU Sydney, AU Wien, AT see more | Locations Cambridge, GB HQ Alger, DZ Buenos Aires, AR Macquarie Park, AU Macquarie Park, AU North Ryde, AU Wien, AT see more | Locations Paris, FR HQ Hydra, DZ Buenos Aires, AR Macquarie Park, AU Melbourne, AU Virginia, AU Wien, AT see more | Locations Dublin, IE HQ Buenos Aires, AR Roseville, AU Machelen, BE Guarulhos, BR Las Condes, CL Bogotá, CO see more | |
Employees | Employees 37,000 | Employees 38,0003% increase | Employees 39,414 | Employees 73,0004% increase | Employees 75,883 | Employees 81,0008% decrease | Employees 94,300 | Employees 103,249 | Employees 82,878 | Employees 10,5471% decrease |
Valuation ($) | Valuation ($) 20.8 b | Valuation ($) 14 b | Valuation ($) 20.7 b | Valuation ($) 294.7 b | Valuation ($) N/A | Valuation ($) 163.9 b | Valuation ($) 2.7 b | Valuation ($) N/A | Valuation ($) 141.1 b | Valuation ($) N/A |
Financial | ||||||||||
Revenue (est.) | Revenue (est.) $17.3b (FY, 2025) | Revenue (est.) $14.3b (FY, 2025) | Revenue (est.) ¥43.1b (FY, 2025) | Revenue (est.) $65b (FY, 2025) | Revenue (est.) $56.7b (FY, 2025) | Revenue (est.) $62.6b (FY, 2025) | Revenue (est.) $58.7b (FY, 2025) | Revenue (est.) CHF61.5b (FY, 2025) | Revenue (est.) €45.4b (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods $8.3b (FY, 2025) | Cost of goods $9.3b (FY, 2025) | Cost of goods ¥23.8b (FY, 2025) | Cost of goods $16.4b (FY, 2025) | Cost of goods $8.4b (FY, 2025) | Cost of goods $16.1b (FY, 2025) | Cost of goods $4.9b (FY, 2025) | Cost of goods CHF13.1b (FY, 2025) | Cost of goods €11.6b (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit $8.9b (FY, 2025) | Gross profit $5b (FY, 2025) | Gross profit ¥21.3b (FY, 2025) | Gross profit $48.6b (FY, 2025) | Gross profit $49.8b (FY, 2025) | Gross profit $46.5b (FY, 2025) | Gross profit $54.2b (FY, 2025) | Gross profit CHF50.5b (FY, 2025) | Gross profit €37.6b (FY, 2025) | Gross profit N/A |
Net income | Net income $1.4b (FY, 2025) | Net income ($3.5b) (FY, 2025) | Net income ¥19.3b (FY, 2025) | Net income $18.3b (FY, 2025) | Net income $14b (FY, 2025) | Net income $7.8b (FY, 2025) | Net income $10.2b (FY, 2025) | Net income CHF13.8b (FY, 2025) | Net income €8b (FY, 2025) | Net income N/A |
Operating ⚠ | ||||||||||
Countries | Countries N/A | Countries 165 (Q1, 2023) | Countries N/A | Countries N/A | Countries N/A | Countries 200 (FY, 2024) | Countries 130 (FY, 2021) | Countries N/A | Countries N/A | Countries 100 (Q1, 2020) |
Facilities | Facilities 90 (FY, 2019) | Facilities N/A | Facilities N/A | Facilities N/A | Facilities N/A | Facilities N/A | Facilities N/A | Facilities N/A | Facilities N/A | Facilities 21 (FY, 2019) |
Manufacturing Sites | Manufacturing Sites N/A | Manufacturing Sites 40 (Q1, 2023) | Manufacturing Sites N/A | Manufacturing Sites N/A | Manufacturing Sites N/A | Manufacturing Sites 37 (FY, 2024) | Manufacturing Sites N/A | Manufacturing Sites N/A | Manufacturing Sites N/A | Manufacturing Sites N/A |
Molecules | Molecules N/A | Molecules 1.4 k (Q1, 2023) | Molecules 2.8 k (H1, 2023) | Molecules N/A | Molecules N/A | Molecules N/A | Molecules N/A | Molecules N/A | Molecules N/A | Molecules N/A |
Patients | Patients N/A | Patients N/A | Patients N/A | Patients N/A | Patients 10 m (FY, 2022) | Patients N/A | Patients N/A | Patients 22.8 m (FY, 2023) | Patients N/A | Patients N/A |
Phase II Trials Products | Phase II Trials Products N/A | Phase II Trials Products N/A | Phase II Trials Products N/A | Phase II Trials Products 85 (FY, 2022) | Phase II Trials Products N/A | Phase II Trials Products 27 (FY, 2024) | Phase II Trials Products N/A | Phase II Trials Products N/A | Phase II Trials Products N/A | Phase II Trials Products N/A |
Phase III Trials Products | Phase III Trials Products N/A | Phase III Trials Products N/A | Phase III Trials Products N/A | Phase III Trials Products 32 (FY, 2022) | Phase III Trials Products 44 (FY, 2022) | Phase III Trials Products 32 (FY, 2024) | Phase III Trials Products N/A | Phase III Trials Products N/A | Phase III Trials Products N/A | Phase III Trials Products N/A |
Projects in R&D Pipeline | Projects in R&D Pipeline N/A | Projects in R&D Pipeline N/A | Projects in R&D Pipeline N/A | Projects in R&D Pipeline N/A | Projects in R&D Pipeline N/A | Projects in R&D Pipeline N/A | Projects in R&D Pipeline 177 (FY, 2021) | Projects in R&D Pipeline N/A | Projects in R&D Pipeline 91 (FY, 2019) | Projects in R&D Pipeline N/A |
Registration Phase Products | Registration Phase Products N/A | Registration Phase Products N/A | Registration Phase Products N/A | Registration Phase Products N/A | Registration Phase Products 8 (FY, 2022) | Registration Phase Products 5 (FY, 2024) | Registration Phase Products N/A | Registration Phase Products N/A | Registration Phase Products N/A | Registration Phase Products N/A |
Funding | ||||||||||
Total funding raised | Total funding raised $ 358m | Total funding raised N/A | Total funding raised $ 902.6m | Total funding raised N/A | Total funding raised $ 6.5m | Total funding raised N/A | Total funding raised $ 1b | Total funding raised $ 7.8b | Total funding raised $ 310m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Viatris
HQ
Canonsburg, US
Employees
38,000↑ 3% increase
Viatris is a pharmaceutical company that develops and manufactures branded and generic medicines, biosimilar medicines, and over-the-counter products.
View companyWuXi AppTec
HQ
Shanghai, CN
Employees
39,414
WuXi AppTec (无锡药明康德新药开发股份有限公司, formerly known as WuXi PharmaTech) is a company that provides integrated research, development, and manufacturing solutions for drug discovery and production.
View companyMerck
HQ
Rahway, US
Employees
73,000↑ 4% increase
Merck (also known as MSD) is a company that develops and manufactures medicines and vaccines for human and animal health.
View companyNovartis
HQ
Basel, CH
Employees
75,883
Novartis is a company that researches, develops, manufactures, and markets healthcare products.
View company